Literature DB >> 3333665

Renal and perirenal abscesses.

J E Patterson1, V T Andriole.   

Abstract

Our knowledge of the spectrum of renal abscesses has increased as a result of more sensitive radiologic techniques. The classification of intrarenal abscess now includes acute focal bacterial nephritis and acute multifocal bacterial nephritis, as well as the previously recognized renal cortical abscess, renal corticomedullary abscess, and xanthogranulomatous pyelonephritis. In general, the clinical presentation of these entities does not differentiate them; various radiographic studies can distinguish them, however. The intrarenal abscess is usually treated successfully with antibiotic therapy alone. Antistaphylococcal therapy is indicated for the renal cortical abscess, whereas therapy directed against the common gram-negative uropathogens is indicated for most of the other entities. The perinephric abscess is often an elusive diagnosis, has a more serious prognosis, and is more difficult to treat. Drainage of the abscess and sometimes partial or complete nephrectomy are required for resolution.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3333665

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Renal and Perinephric Abscesses Revisited.

Authors:  R S Rai; S C Karan; A Kayastha
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage.

Authors:  Seung Hwan Lee; Hyun Jin Jung; Sang Yol Mah; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

3.  Infected simple renal cyst due to Streptococcus pneumoniae rapidly diagnosed by the melting temperature mapping method: a case report.

Authors:  Yoji Uejima; Hideki Niimi; Reiko Kato; Mihoko Furuichi; Satoshi Sato; Isao Kitajima; Yutaka Kawano; Tsutomu Oh-Ishi; Hiroshi Kawashima; Eisuke Suganuma
Journal:  BMC Pediatr       Date:  2021-06-05       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.